Document is current
Any future updates will be listed below
-
Authors
Hildebrand, Laura S.
Jost, Tina
Schindler, Marion
Derer, Anja
Fuhrmann, Gregor
Fietkau, Rainer
Distel, Luitpold V.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Erlangen
- License Information
-
More Information
Article History
Received: 7 February 2025
Accepted: 19 May 2025
First Online: 22 May 2025
Declarations
:
: The authors declare no competing interests.
: The established and commercially available HNSCC cell lines were provided by Dr. Thorsten Rieckmann (University Medical Centre Hamburg-Eppendorf, Germany) or purchased from CLS Cell Lines Service GmbH (Eppelheim, Germany). Fibroblast cell lines were obtained by biopsy and donors signed the informed consent. The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the medical faculty of the Friedrich-Alexander-Universität Erlangen-Nürnberg (204_17 BC) on August 18, 2017. Informed consent was obtained from all subjects involved in the study.
